Related Experiment Video
Updated: Jul 3, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
What causes itch in atopic dermatitis?
Gil Yosipovitch1, Alexandru D P Papoiu
1Departments of Dermatology and Neurobiology and Anatomy, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. gyosipov@wfubmc.edu
Itch in atopic dermatitis involves complex interactions between skin barrier, immune cells, and nerves. New research highlights key mediators like interleukin 31 in this debilitating condition.
Area of Science:
- Dermatology
- Neuroscience
- Immunology
Background:
- Atopic dermatitis is characterized by intense itch, significantly impacting patient quality of life.
- The pathophysiology of atopic eczema itch involves intricate cross-talk between skin components and nerve fibers.
- Impaired skin barrier function exacerbates the itch-scratch cycle, worsening the condition.
Purpose of the Study:
- To review the peripheral and central mechanisms underlying itch in atopic dermatitis.
- To identify and discuss key mediators involved in the pathogenesis of atopic dermatitis itch.
- To synthesize recent advances in understanding neural sensitization in atopic dermatitis.
Main Methods:
- Literature review of current research on atopic dermatitis itch.
- Analysis of studies investigating central and peripheral mechanisms of itch.
- Identification of novel mediators implicated in atopic dermatitis pathogenesis.
Main Results:
- Significant cross-talk exists among the stratum corneum, keratinocytes, immune cells, and nerve fibers, contributing to itch.
- Peripheral and central neural sensitization of nerve fibers play a crucial role in atopic dermatitis itch.
- New mediators such as serine proteases, interleukin 31 (IL-31), and nerve growth factor (NGF) are associated with atopic dermatitis itch.
Conclusions:
- Understanding the complex interplay of mediators and neural pathways is essential for managing atopic dermatitis itch.
- Targeting specific mediators like IL-31 and NGF may offer new therapeutic strategies.
- Further research into peripheral and central mechanisms can lead to improved treatments for atopic dermatitis.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Allergic Reactions
Drug Toxicity: Allergic Reactions
Asthma I: Introduction
Staphylococcal Skin Infections
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

